These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17262187)

  • 1. Comment on Mackenzie and Woodhouse: C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction.
    Droogh JM; Noppers IM; Tulleken JE; Meertens JH; Ligtenberg JJ; Monteban-Kooistra WE; Zijlstra JG
    Intensive Care Med; 2007 Mar; 33(3):561; author reply 563-4. PubMed ID: 17262187
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction.
    Mackenzie I; Woodhouse J
    Intensive Care Med; 2006 Sep; 32(9):1344-51. PubMed ID: 16799774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis.
    Park WB; Lee KD; Lee CS; Jang HC; Kim HB; Lee HS; Oh MD; Choe KW
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):227-30. PubMed ID: 15808312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein level as a predictor of mortality in liver disease patients with bacteremia.
    Janum SH; Søvsø M; Gradel KO; Schønheyder HC; Nielsen H
    Scand J Gastroenterol; 2011 Dec; 46(12):1478-83. PubMed ID: 21905978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-reactive protein and liver disease in patients with melioidosis.
    Cheng AC; Currie BJ
    Intensive Care Med; 2007 Mar; 33(3):562; author reply 563-4. PubMed ID: 17262186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress of endotoxin and chronic liver disease].
    Wang L; Ren CS
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):251-3. PubMed ID: 12716536
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of liver disease in patients with Streptococcus bovis bacteraemia.
    Gonzlez-Quintela A; Martínez-Rey C; Castroagudín JF; Rajo-Iglesias MC; Domínguez-Santalla MJ
    J Infect; 2001 Feb; 42(2):116-9. PubMed ID: 11531317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin in the assessment of bacteraemia in emergency department patients: results of a large retrospective study.
    Kim SY; Jeong TD; Lee W; Chun S; Min WK
    Ann Clin Biochem; 2015 Nov; 52(Pt 6):654-9. PubMed ID: 25575698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
    Stokes CS; Volmer DA
    Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the action of C-reactive proteins in relation to current liver tests].
    Renger F; Kanehl R; Kanehl E
    Acta Hepatosplenol; 1965; 12(6):337-51. PubMed ID: 5868476
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive factors of bacteraemia in low-risk patients with febrile neutropenia.
    Ahn S; Lee YS; Chun YH; Lim KS; Kim W; Lee JL
    Emerg Med J; 2012 Sep; 29(9):715-9. PubMed ID: 22011971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of lymphadenopathy with liver dysfunction due to Mycoplasma pneumoniae infection with mycoplasmal bacteraemia without pneumonia.
    Narita M; Yamada S; Nakayama T; Sawada H; Nakajima M; Sageshima S
    J Infect; 2001 Feb; 42(2):154-6. PubMed ID: 11531323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic use of C-reactive protein in bacteraemic emergency department patients.
    Adams NG
    Emerg Med Australas; 2005 Aug; 17(4):371-5. PubMed ID: 16091100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.
    Ashare A; Stanford C; Hancock P; Stark D; Lilli K; Birrer E; Nymon A; Doerschug KC; Hunninghake GW
    Clin Transl Sci; 2009 Jun; 2(3):199-205. PubMed ID: 20443893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards.
    Ratzinger F; Haslacher H; Perkmann T; Schmetterer KG; Poeppl W; Mitteregger D; Dorffner G; Burgmann H
    Eur J Clin Invest; 2015 Aug; 45(8):815-23. PubMed ID: 26046926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of C-reactive protein levels in patients with cirrhosis.
    Di Martino V; Coutris C; Cervoni JP; Dritsas S; Weil D; Richou C; Vanlemmens C; Thevenot T
    Liver Transpl; 2015 Jun; 21(6):753-60. PubMed ID: 25677965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood level of mexiletine in liver-damaged patients].
    Winter M; Brunner H; Horwatitsch H; Grabner G
    Adv Clin Pharmacol; 1978; 16():29-32. PubMed ID: 685749
    [No Abstract]   [Full Text] [Related]  

  • 18. Discrepancies between plasma procalcitonin and C-reactive protein levels are common in acute illness.
    Ivaska L; Elenius V; Mononen I; Ruuskanen O; Peltola V
    Acta Paediatr; 2016 May; 105(5):508-13. PubMed ID: 26644355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocyte changes during alcoholism and chronic liver diseases].
    Triolo L; Magris D; Mian G; D'Agnolo B
    Arch Sci Med (Torino); 1978; 135(4):477-83. PubMed ID: 756712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
    Montagnese S; Biancardi A; Schiff S; Carraro P; Carlà V; Mannaioni G; Moroni F; Tono N; Angeli P; Gatta A; Amodio P
    Hepatology; 2011 Feb; 53(2):558-66. PubMed ID: 21274876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.